Browse
Submit Data
Databases
API
Help

Dataset Information

7 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Feasibility of Enhanced Recovery after Surgery protocol in patients undergoing gastrointestinal cancer surgeries

ABSTRACT: Primary outcome(s): Compliance rate of ERAS protocolTimepoint: During pre operative, intra operative and post operative period till discharge of the patient

DISEASE(S): Malignant Neoplasm Of Rectum,Malignant Neoplasm Of Overlappingsites Of Rectum, Anus And Anal Canal,Malignant Neoplasm Of Rectosigmoidjunction,Malignant Neoplasm Of Colon, Unspecified,Malignant Neoplasm Of Gallbladder,Malignant Neoplasm Of Liver, Primary, Unspecified As To Type,Malignant Neoplasm Of Small Intestine, Unspecified,Malignant Neoplasm Of Esophagus, Unspecified,Malignant Neoplasm Of Stomach, Unspecified,Malignant Neoplasm Of Pancreas, Unspecified,Malignant Neoplasm Of Ill-definedsites Within The Digestive System

PROVIDER: 2728093 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Colorectal Cancer Surgery

Project description:The study assesses the impact on quality of care of implementing the ERAS (Enhanced Recovery After Surgery) protocol for colorectal cancer surgery in the network of public hospitals in the Regione Piemonte (North-West Italy). Every hospital is a cluster entering the study treating patients according to its current clinical practice. On the basis of a randomized order, each hospital switches from current clinical practice to the adoption of the ERAS protocol.

| 2312299 | ecrin-mdr-crc

Single Incision Plus One Port Laparoscopic Surgery Assistant Enhanced Recovery After Surgery on Colorectal Cancer

Project description:Conventional laparoscopic surgery (CLS) for colorectal cancer has been demonstrated to be safe and feasible and present minimally invasive benefits including faster recovery, reduced postoperative pain and shorter hospital stay, also acquiring comparable oncologic outcomes with open surgery. To achieve further minimally invasive outcomes, SILS plus one port surgery was attempted by some surgeons. Preliminary results showed that SILS+1 could achieve better minimally invasive benefits than CLS while preserving oncologic feasibility. Till now, ERAS has been practiced in colorectal cancer surgery for approximately 20 years. Studies have proven that ERAS is safe and significantly improved the recovery course of patients during perioperative period, meanwhile, the expense could be greatly reduced. Based on ERAS studies protocols and SILS+1 trials, investigators tried to combine SILS+1 with ERAS, hopefully to provide patients with more safe, economic, feasible and rapid surgery and perioperative strategies.

| 2330011 | ecrin-mdr-crc

Prehabilitation Versus Enhanced Recovery Program for Elective Colorectal Cancer Surgery.

Project description:Elective surgery is the most effective treatment option for colorectal cancer, however it has been recognized to be associated with high morbidity and mortality risks. ERAS (Enhanced Recovery After Surgery) is a preoperative multimodality treatment package, which has been well investigated and proved to be effective in reducing early postoperative morbidity, mortality, length of hospital stay and hospital costs, as well. Still, a good proportion of patients are not suitable for ERAS program, mainly based on lack of compliance and the impaired physical function before surgery. Prehabilitation Program is a recently introduced trimodal preoperative preparation (training) program, which addresses improvement of physical, mental and nutritional status of the high risk elective surgery patients. This study aims to investigate the benefit of all efforts of a 4-6-week preoperative preparation program (Prehabilitation) being added to an established ERAS protocol.

| 2290828 | ecrin-mdr-crc

Paramecium tetraurelia trichocyst exocytosis recovery

Project description:Paramecium cells possess a few thousand trichocysts (big secretory granules of 3~4 um long) docked at their surface and whose discharge in the external medium can be triggered using aminoethyldextran (a modified dextran positively charged) without damage to the cells. After discharge, new trichocysts are re-synthesized by the cells. We studied the evolution of the transcriptome during this synthesis.

2010-07-07 | GSE17930 | GEO

Feasibility of ERAS Protocol in T4 Colorectal Cancer Patients

Project description:Patients diagnosed with T4 colorectal cancer represent a specific subgroup of colorectal patients, frequently composed of fragile patients whose advanced nature of the disease often requires a multi organ resection by an open surgery approach and frequently leads to higher intra/postoperative complication.Those characteristics makes them to be considered less suitable for ERAS protocol, especially regarding an expected difficult compliance to postoperative items. The impact of enhanced recovery program on postoperative outcomes in this subset of patients has never been addressed in literature, in fact most of studies either excluded T4 patients due to higher rates of complication or adopted an homogeneous patient sampling analizing all stage colorectal cancer together. Our aim is to investigate the feasibility of ERAS protocol in T4 colorectal patient, primary outcome was to compare postoperative lenght of stay between T4 colorectal patients treated with ERAS protcol and those treated with standard of care.

| 2345247 | ecrin-mdr-crc

Implementation of the pre-operative rehabilitation recovery protocol and its effect on the quality of recovery after colorectal surgeries.

Project description: Not available

| S-EPMC8667982 | biostudies-literature

Long-term Enlarged Survival After an Enhanced Recovery Protocol (LESAS).

Project description:The main objective of this study is to analyze the impact on three years survival of an enhanced recovery program (PRI) after radical surgery for colorectal cancer. As secondary objectives, we propose to analyze the weight of each of the predefined items in the oncological results as well as the quality of life. We design a multicentric prospective cohort study in people older than 18 years who are going to be operated on for colorectal cancer. 12 hospitals are being selected due to have a PRI implanted according to the RICA pathway published by the Spanish National Health Service. As stated by the literature, the intervention group will be formed for those hospitals with a minimum implementation level of 70% of the PRI and the control group will be the centers that do not reach this level of implementation. Compliance will be studied with 21 key performance indicators and results are analyzed with cancer survival indicators: Overall survival, cancer-specific survival and relapse-free survival). We will also study the time to recurrence, perioperative morbi-mortality, hospital stay and quality of life with the EQ-5D validated questionary. To create comparable treatment and control groups, the Propensity Index method will be used. To study each variable, multivariate regression will be used. Kaplan-Meier will be used for survival and the log-rank test for comparisons. Significance will be considered if p <0.05 (two tails).

| 2332853 | ecrin-mdr-crc

Central nervous system immune response in postinfectious hydrocephalus

Project description:Intra-operative ventricular cerebrospinal fluid obtained from infants with post-infectious and non-post-infectious hydrocephalus

2021-03-18 | MSV000087068 | MassIVE

Oncologic and long-term outcomes of enhanced recovery after surgery in cancer surgeries - a systematic review.

Project description: Not available

| S-EPMC8243430 | biostudies-literature

The effectiveness and safety of perioperative Enhanced Recovery After Surgery protocol in robot assisted laparoscopic colorectal surgery by da Vinci Si Surgical System.

Project description:Interventions: perioperative ERAS protocol Primary outcome(s): rate of the incidence of postoperative complications further than Grade 3 of Clavien-Dindo classification ver2.0. Study Design: Single arm Non-randomized

| 2638948 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data